openPR Logo
Press release

Massive growth of Tardive Dyskinesia Therapeutics Market by 2032 with key players such as Allergan, Contera Pharma, Johnson & Johnson Services Inc., Lannett Co. Inc.

09-27-2024 07:44 AM CET | Health & Medicine

Press release from: Polaris Market Research & Consulting

Tardive Dyskinesia Therapeutics Market

Tardive Dyskinesia Therapeutics Market

The ongoing escalation in the aggregate of schizophrenia patients globally has been an influential factor in the increasing growth and revenue of the tardive dyskinesia therapeutics industry. Based on drug analysis, the valbenazine segment accounted for the highest share. By region, North America led the market.

๐“๐ก๐ข๐ฌ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐€๐๐๐ซ๐ž๐ฌ๐ฌ๐ž๐ฌ:
โ€ข The global tardive dyskinesia therapeutics market was valued at USD 3.83 billion in 2023 and is expected to grow to USD 5.57 billion by 2032.

โ€ข The market is anticipated to exhibit a CAGR of 4.3% during the forecast period.

โ€ข The market is mainly segmented on the basis of drug, product type, distribution channel, and region.

โ€ข North America accounted for the largest market share.

๐†๐ž๐ญ ๐„๐ฑ๐œ๐ฅ๐ฎ๐ฌ๐ข๐ฏ๐ž ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐๐š๐ ๐ž๐ฌ ๐จ๐Ÿ ๐“๐ก๐ข๐ฌ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ:
https://www.polarismarketresearch.com/industry-analysis/tardive-dyskinesia-therapeutics-market/request-for-sample

๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Ž๐ฏ๐ž๐ซ๐ฏ๐ข๐ž๐ฐ:
Tardive dyskinesia is a neurological ailment that includes unconditioned movements. Consuming antipsychotic medications is the root cause of this condition. This condition advances due to the usage of dopamine receptor-obstructing medications.

The disease can be managed by reducing the dose or halting the antipsychotic medication. If one develops tardive dyskinesia while consuming first-generation antipsychotic medication, the donor may shift to a second-generation antipsychotic medication. Other than halting or shifting antipsychotic medication, the robust proof of TD treatment is the usage of VMAT inhibitors deutetrabenazine and valbenazine.

๐‚๐จ๐ฆ๐ฉ๐ž๐ญ๐ข๐ญ๐ข๐จ๐ง ๐ƒ๐ž๐ž๐ฉ ๐ƒ๐ข๐ฏ๐ž:
The market is excessively splintered in nature with the strong existence of worldwide market players. Some of the prominent players operating in the tardive dyskinesia therapeutics market include:
โ€ข Allergan
โ€ข Contera Pharma
โ€ข Johnson & Johnson Services Inc.
โ€ข Lannett Co. Inc.
โ€ข Luye Pharma Group
โ€ข Mitsubishi Tanabe Pharma Corporation
โ€ข Neurocrine Biosciences Inc.
โ€ข Prestwick Pharmaceuticals Inc.
โ€ข Reddy Laboratories Ltd.
โ€ข SOM Biotech
โ€ข SteriMax Inc.
โ€ข Sun Pharmaceutical Industries Ltd.
โ€ข Teva Pharmaceutical Industries Ltd.
โ€ข Valeant Pharmaceuticals

๐๐ฎ๐ฒ ๐๐จ๐ฐ ๐“๐ก๐ข๐ฌ ๐๐ซ๐ž๐ฆ๐ข๐ฎ๐ฆ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ:
https://www.polarismarketresearch.com/buy/3662/2

๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐ƒ๐ซ๐ข๐ฏ๐ž๐ซ๐ฌ:
There is a growing existence of tardive dyskinesia globally that has escalated the demand for productive cures and therapeutic solutions. It is a significant kind of movement illness that takes place as a ramification of prolonged usage of several kinds of psychiatric medications such as antipsychotics. Further, there are several firms in the market concentrating on acquiring product consent from several administrative powers involving the US Food and Drug Administration, which is driving up the tardive dyskinesia therapeutics market demand.

๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง ๐Ž๐ฏ๐ž๐ซ๐ฏ๐ข๐ž๐ฐ:
๐๐ฒ ๐ƒ๐ซ๐ฎ๐ :
โ€ข Deutetrabenazine
โ€ข Valbenazine
โ€ข Others

๐๐ฒ ๐๐ซ๐จ๐๐ฎ๐œ๐ญ ๐“๐ฒ๐ฉ๐ž:
โ€ข Solid Dosage Form
โ€ข Tablets
โ€ข Capsules
โ€ข Liquid Dosage Form
โ€ข Injection

๐๐ฒ ๐ƒ๐ข๐ฌ๐ญ๐ซ๐ข๐›๐ฎ๐ญ๐ข๐จ๐ง ๐‚๐ก๐š๐ง๐ง๐ž๐ฅ:
โ€ข Hospitals Pharmacies
โ€ข Drug Stores & Retail Pharmacies
โ€ข Online Pharmacies
โ€ข Others

๐‚๐ฅ๐ข๐œ๐ค ๐ก๐ž๐ซ๐ž ๐ญ๐จ ๐€๐œ๐œ๐ž๐ฌ๐ฌ ๐ญ๐ก๐ž ๐…๐ฎ๐ฅ๐ฅ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ:
https://www.polarismarketresearch.com/industry-analysis/tardive-dyskinesia-therapeutics-market

๐Œ๐จ๐ซ๐ž ๐“๐ซ๐ž๐ง๐๐ข๐ง๐  ๐‹๐š๐ญ๐ž๐ฌ๐ญ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ ๐›๐ฒ ๐๐จ๐ฅ๐š๐ซ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก:
๐‡๐ฎ๐ฆ๐š๐ง ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐‡๐จ๐ซ๐ฆ๐จ๐ง๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ:
https://www.polarismarketresearch.com/industry-analysis/human-growth-hormone-market

๐Œ๐ž๐ง๐ญ๐š๐ฅ ๐‡๐ž๐š๐ฅ๐ญ๐ก ๐’๐œ๐ซ๐ž๐ž๐ง๐ข๐ง๐  ๐Œ๐š๐ซ๐ค๐ž๐ญ:
https://www.polarismarketresearch.com/industry-analysis/mental-health-screening-market

๐‚๐ž๐ง๐ญ๐ซ๐š๐ฅ ๐‹๐š๐› ๐Œ๐š๐ซ๐ค๐ž๐ญ:
https://www.polarismarketresearch.com/industry-analysis/central-lab-market

๐€๐ง๐š๐ฅ๐ฒ๐ญ๐ข๐œ๐š๐ฅ ๐’๐ญ๐š๐ง๐๐š๐ซ๐๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ:
https://www.polarismarketresearch.com/industry-analysis/analytical-standards-market

๐Œ๐ž๐๐ข๐œ๐š๐ฅ ๐–๐š๐ฌ๐ญ๐ž ๐Œ๐š๐ง๐š๐ ๐ž๐ฆ๐ž๐ง๐ญ ๐Œ๐š๐ซ๐ค๐ž๐ญ:
https://www.polarismarketresearch.com/industry-analysis/medical-waste-management-market

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐ˆ๐ง๐Ÿ๐จ:
Polaris Market Research
30 Wall Street, 8th Floor,
New York City, NY 10005,
United States
Phone:+1-929 297-9727
Email: sales@polarismarketresearch.com

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ:
Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defence, among different ventures present globally.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Massive growth of Tardive Dyskinesia Therapeutics Market by 2032 with key players such as Allergan, Contera Pharma, Johnson & Johnson Services Inc., Lannett Co. Inc. here

News-ID: 3669947 • Views: โ€ฆ

More Releases from Polaris Market Research & Consulting

Self-Hosted Cloud Platform Market to Expand at 11.9% CAGR, Reaching USD 49.67 Billion by 2034
Self-Hosted Cloud Platform Market to Expand at 11.9% CAGR, Reaching USD 49.67 Bi โ€ฆ
Polaris Market Research recently introduced the latest update on Self-Hosted Cloud Platform Market that provides an extensive outlook of the market, analyzing key growth opportunities, challenges, risk factors, and emerging trends across diverse geographic regions. The report offers a definitive and meticulous analysis of the Self-Hosted Cloud Platform Market size, share, demand, key growth factors, segmentation, country-level overview, and forecast. The report helps businesses get a thorough understanding of theโ€ฆ
Medical Device Design and Development Services Market Growing Trends and Demands Analysis Forecast 2026 to 2034 | Veranex, Donatelle, Cirtec
Medical Device Design and Development Services Market Growing Trends and Demands โ€ฆ
Market Size and Share: Global Medical Device Design and Development Services Market is currently valued at USD 12.61 Billion in 2025 and is anticipated to generate an estimated revenue of USD 41.91 Billion by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 14.27% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2026 - 2034 Polaris Market Research has introducedโ€ฆ
Automated Test Equipment Market Projected to Reach USD 11.40 Billion by 2034, Growing at a CAGR of 3.3%.
Automated Test Equipment Market Projected to Reach USD 11.40 Billion by 2034, Gr โ€ฆ
Market Size and Share: Global Automated Test Equipment Market is currently valued at USD 8.24 billion in 2025 and is anticipated to generate an estimated revenue of USD 11.40 billion by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 3.3% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2026 - 2034 Polaris Market Research has introduced the latest marketโ€ฆ
Building Information Modeling (BIM) Market to Reach USD 21.06 Billion by 2034, Growing at a CAGR of 10.3%
Building Information Modeling (BIM) Market to Reach USD 21.06 Billion by 2034, G โ€ฆ
Polaris Market Research recently introduced the latest update on Building Information Modeling Market that provides an extensive outlook of the market, analyzing key growth opportunities, challenges, risk factors, and emerging trends across diverse geographic regions. The report offers a definitive and meticulous analysis of the Building Information Modeling Market size, share, demand, key growth factors, segmentation, country-level overview, and forecast. The report helps businesses get a thorough understanding of theโ€ฆ

All 5 Releases


More Releases for Pharma

Schizophrenia Market: Expanding Revenue Landscape to 2034 - DelveInsight | Teva โ€ฆ
The Key Schizophrenia Companies in the market inlclude - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Reviva Pharmaceuticals, and others. DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2034" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed insights into the disease, including historical and projected epidemiology, helping stakeholders understand theโ€ฆ
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi โ€ฆ
๐”๐’๐€, ๐๐ž๐ฐ ๐‰๐ž๐ซ๐ฌ๐ž๐ฒ- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasingโ€ฆ
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi โ€ฆ
๐”๐’๐€, ๐๐ž๐ฐ ๐‰๐ž๐ซ๐ฌ๐ž๐ฒ- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. Asโ€ฆ
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh โ€ฆ
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of theโ€ฆ
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, โ€ฆ
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoringโ€ฆ
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 โ€ฆ
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about theโ€ฆ